Measure it per prescription first: what the payer pays, less what the drug cost after the rebate, payer by payer and generic against brand.
An independent pharmacy earns its margin one claim at a time. In the book's case a Part D generic paid $17.10 after the price concession leaves $9.39, a Part D brand paid $475.52 leaves $7.52, and the store averages $10.80 per prescription: 16.3 percent of prescription revenue, and EBITDA of 1.24 percent of all revenue.
The gross margin of a prescription is what the pharmacy is paid for it, the payer's share and the patient's copay together, less what the drug cost, net of any rebate from the wholesaler. Pharmacist and technician pay, rent, software and the owner come later, in the store's contribution and in EBITDA.
Margin per prescription = payment (payer + copay, after any price concession at the point of sale) − acquisition cost × (1 − generic rebate)
Since 1 January 2024 the negotiated price of a Part D drug includes every pharmacy price concession (42 CFR 423.100), so the concession is known at the counter instead of being charged back months later as a DIR fee. That makes the margin of a Part D claim readable on the day it is filled.
The case buys a generic at $7.95 on the invoice and earns a 3 percent rebate from its primary wholesaler: the net cost is $7.71. A Part D plan contracts at $18.45 and takes a $1.35 price concession at the point of sale, so it pays $17.10 and leaves $9.39. The state Medicaid program pays its acquisition cost benchmark of $8.35 plus a professional dispensing fee of $10.48 and leaves $11.12. The cash price of $21.50 leaves the most, $13.79.
Worked in full in The Independent Pharmacy Owner by Julian R. Sterling.Get the DRM-free PDF, $19.99 →or the paperback
Free: the pharmacy margin per prescription and break-even calculator in Excel: the margin of a generic and a brand, and the prescriptions a day your store needs.
A brand costs the case $468.00. Part D pays acquisition plus 2.4 percent, less a concession of 0.9 percent of acquisition, plus a $0.50 dispensing fee: $475.52, a margin of $7.52, or 1.6 percent of the payment, against 54.9 percent on the Part D generic. A brand carries hundreds of dollars of revenue and a few dollars of margin; a generic carries the margin.
| Prescription | Paid | Net cost | Margin |
|---|---|---|---|
| Generic, Medicare Part D | $17.10 | $7.71 | $9.39 |
| Generic, Commercial | $19.85 | $7.71 | $12.14 |
| Generic, Medicaid | $18.83 | $7.71 | $11.12 |
| Generic, Cash | $21.50 | $7.71 | $13.79 |
| Brand, Medicare Part D | $475.52 | $468.00 | $7.52 |
| Brand, Commercial | $483.83 | $468.00 | $15.83 |
| Brand, Medicaid | $479.88 | $468.00 | $11.88 |
The trap: quoting one payer's generic margin as "the margin". The store's figure is the average over every claim it filled, brands, selected drugs and every payer included, and it moves with the mix.
In the case, FY2026 prescription revenue of $8,998,508 left an Rx gross margin of $1,471,110 on 136,177 prescriptions: $10.80 per prescription and 16.3 percent of Rx revenue, down from $10.93 the year before. Selected drugs with a maximum fair price leave only their $0.50 dispensing fee, and the manufacturer's refund of the gap arrives weeks later.
Technicians, pharmacists other than the owner, clerks, the driver, rent, insurance, software and the PSAO come out of the store's margin, then the company's overhead, including the owner's salary as pharmacist-in-charge. On revenue of $9,718,460 the case kept EBITDA of $120,131 in FY2026, 1.24 percent, after a second store's first year. A cut of 25 cents on each of its 90,364 generics paid by a PBM (Part D and commercial; cash and Medicaid prices are not the PBM's) would have taken $22,591 more.
The generic share, the payer mix, the PBM's MAC list and its appeals, the wholesaler's terms and rebate, the cash price list, and the share of claims paid below acquisition cost. Each one is a line a pharmacy owner can read in the claims report before signing next year's contracts.
Figures checked on 18 November 2026. The pharmacy in the examples is fictional and its figures are teaching assumptions, not market norms. Not legal, tax, pharmacy practice or lending advice.
It depends on the payer and the drug. In the book's fictional case a Part D generic leaves $9.39, a commercial generic $12.14, a Part D brand $7.52, and the store averages $10.80 per prescription.
A brand is paid at a small markup on a large cost, so its margin is a few dollars on hundreds; a generic costs a few dollars and is paid a fixed amount well above that.
Since 1 January 2024, Part D pharmacy price concessions are included in the negotiated price at the point of sale (42 CFR 423.100), so they show on the claim rather than as a later clawback.
No single figure holds: most revenue is drug cost passed through. Compute your own from your statements; the book's case kept 2.81 percent in its first year and 1.24 percent in the year it opened a second store.
This article is one calculation from The Independent Pharmacy Owner, a practitioner’s guide to running a community pharmacy by the numbers: PBM and Medicare Part D reimbursement, the margin per prescription, inventory and wholesaler terms, price concessions, the front end and clinical services, staffing, cash flow, a second store and what the pharmacy is worth.
DRM-free PDF, $19.99 · Paperback, $32.99, shipped worldwide · Free Excel calculator